☰

Zachary A. Gurard-Levin, Ph.D. - Publications

Affiliations: 
2010 Chemistry University of Chicago, Chicago, IL 
Area:
chemical biology of cell adhesion
Tree Info Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Scholle MD, O'Kane PT, Dib S, Gurard-Levin ZA. Label-free duplex SAMDI-MS screen reveals novel SARS-CoV-2 3CLpro inhibitors. Antiviral Research. 200: 105279. PMID 35278580 DOI: 10.1016/j.antiviral.2022.105279  0.62
2021 Scholle MD, McLaughlin D, Gurard-Levin ZA. High-Throughput Affinity Selection Mass Spectrometry Using SAMDI-MS to Identify Small-Molecule Binders of the Human Rhinovirus 3C Protease. Slas Discovery : Advancing Life Sciences R & D. 24725552211023211. PMID 34151629 DOI: 10.1177/24725552211023211  0.358
2021 Scholle MD, McLaughlin D, Gurard-Levin ZA. High-Throughput Affinity Selection Mass Spectrometry Using SAMDI-MS to Identify Small-Molecule Binders of the Human Rhinovirus 3C Protease. Slas Discovery : Advancing Life Sciences R & D. 24725552211023211. PMID 34151629 DOI: 10.1177/24725552211023211  0.358
2021 Scholle MD, Liu C, Deval J, Gurard-Levin ZA. Label-Free Screening of SARS-CoV-2 NSP14 Exonuclease Activity Using SAMDI Mass Spectrometry. Slas Discovery : Advancing Life Sciences R & D. 24725552211008854. PMID 33870746 DOI: 10.1177/24725552211008854  0.386
2021 Scholle MD, Gurard-Levin ZA. Development of a Novel Label-Free and High-Throughput Arginase-1 Assay Using Self-Assembled Monolayer Desorption Ionization Mass Spectrometry. Slas Discovery : Advancing Life Sciences R & D. 24725552211000677. PMID 33754845 DOI: 10.1177/24725552211000677  0.342
2021 Liu C, Boland S, Scholle MD, Bardiot D, Marchand A, Chaltin P, Blatt LM, Beigelman L, Symons JA, Raboisson P, Gurard-Levin ZA, Vandyck K, Deval J. Dual Inhibition of SARS-CoV-2 and Human Rhinovirus with Protease Inhibitors in Clinical Development. Antiviral Research. 105020. PMID 33515606 DOI: 10.1016/j.antiviral.2021.105020  0.341
2020 Gurard-Levin ZA, Liu C, Jekle A, Jaisinghani R, Ren S, Vandyck K, Jochmans D, Leyssen P, Neyts J, Blatt LM, Beigelman L, Symons JA, Raboisson P, Scholle MD, Deval J. Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry. Antiviral Research. 104924. PMID 32896566 DOI: 10.1016/J.Antiviral.2020.104924  0.421
2020 Saavedra F, Gurard-Levin ZA, Rojas-Villalobos C, Vassias I, Quatrini R, Almouzni G, Loyola A. JMJD1B, a novel player in histone H3 and H4 processing to ensure genome stability. Epigenetics & Chromatin. 13: 6. PMID 32070414 DOI: 10.1186/S13072-020-00331-1  0.405
2019 Bakail M, Gaubert A, Andreani J, Moal G, Pinna G, Boyarchuk E, Gaillard MC, Courbeyrette R, Mann C, Thuret JY, Guichard B, Murciano B, Richet N, Poitou A, Frederic C, ... ... Gurard-Levin ZA, et al. Design on a Rational Basis of High-Affinity Peptides Inhibiting the Histone Chaperone ASF1. Cell Chemical Biology. PMID 31543461 DOI: 10.1016/J.Chembiol.2019.09.002  0.481
2018 Clément C, Orsi GA, Gatto A, Boyarchuk E, Forest A, Hajj B, Miné-Hattab J, Garnier M, Gurard-Levin ZA, Quivy JP, Almouzni G. High-resolution visualization of H3 variants during replication reveals their controlled recycling. Nature Communications. 9: 3181. PMID 30093638 DOI: 10.1038/S41467-018-05697-1  0.362
2017 Saavedra F, Rivera C, Rivas E, Merino P, Garrido D, Hernández S, Forné I, Vassias I, Gurard-Levin ZA, Alfaro IE, Imhof A, Almouzni G, Loyola A. PP32 and SET/TAF-Iβ proteins regulate the acetylation of newly synthesized histone H4. Nucleic Acids Research. PMID 28977641 DOI: 10.1093/Nar/Gkx775  0.42
2016 Gurard-Levin ZA, Wilson LO, Pancaldi V, Postel-Vinay S, Sousa FG, Reyes C, Marangoni E, Gentien D, Valencia A, Pommier Y, Cottu P, Almouzni G. Chromatin regulators as a guide for cancer treatment choice. Molecular Cancer Therapeutics. PMID 27196757 DOI: 10.1158/1535-7163.Mct-15-1008  0.38
2016 Gurard-Levin ZA, Wilson LO, Pancaldi V, Postel-Vinay S, Sousa FG, Reyes C, Marangoni E, Gentien D, Valencia A, Pommier Y, Cottu P, Almouzni G. Abstract LB-129: Epigenetic regulators to predict docetaxel sensitivity; a guide for treatment choice Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-129  0.359
2015 Rivera C, Saavedra F, Alvarez F, Díaz-Celis C, Ugalde V, Li J, Forné I, Gurard-Levin ZA, Almouzni G, Imhof A, Loyola A. Methylation of histone H3 lysine 9 occurs during translation. Nucleic Acids Research. PMID 26405197 DOI: 10.1093/Nar/Gkv929  0.436
2015 Montes de Oca R, Gurard-Levin ZA, Berger F, Rehman H, Martel E, Corpet A, de Koning L, Vassias I, Wilson LO, Meseure D, Reyal F, Savignoni A, Asselain B, Sastre-Garau X, Almouzni G. The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma. Molecular Oncology. 9: 657-74. PMID 25497280 DOI: 10.1016/J.Molonc.2014.11.002  0.352
2015 Gurard-Levin ZA, Pancaldi V, Wilson LO, Marangoni E, Roman-Roman S, Valencia A, Cottu P, Almouzni G. Abstract LB-155: Epigenetic profiling of chemotherapy sensitivity Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-155  0.307
2014 Gurard-Levin ZA, Almouzni G. Histone modifications and a choice of variant: a language that helps the genome express itself. F1000prime Reports. 6: 76. PMID 25343033 DOI: 10.12703/P6-76  0.457
2014 Gurard-Levin ZA, Quivy JP, Almouzni G. Histone chaperones: assisting histone traffic and nucleosome dynamics. Annual Review of Biochemistry. 83: 487-517. PMID 24905786 DOI: 10.1146/Annurev-Biochem-060713-035536  0.43
2014 Rivera C, Gurard-Levin ZA, Almouzni G, Loyola A. Histone lysine methylation and chromatin replication. Biochimica Et Biophysica Acta. 1839: 1433-9. PMID 24686120 DOI: 10.1016/J.Bbagrm.2014.03.009  0.412
2013 Abascal F, Corpet A, Gurard-Levin ZA, Juan D, Ochsenbein F, Rico D, Valencia A, Almouzni G. Subfunctionalization via adaptive evolution influenced by genomic context: the case of histone chaperones ASF1a and ASF1b. Molecular Biology and Evolution. 30: 1853-66. PMID 23645555 DOI: 10.1093/Molbev/Mst086  0.354
2011 Cook AJ, Gurard-Levin ZA, Vassias I, Almouzni G. A specific function for the histone chaperone NASP to fine-tune a reservoir of soluble H3-H4 in the histone supply chain. Molecular Cell. 44: 918-27. PMID 22195965 DOI: 10.1016/J.Molcel.2011.11.021  0.417
2011 Gurard-Levin ZA, Scholle MD, Eisenberg AH, Mrksich M. High-throughput screening of small molecule libraries using SAMDI mass spectrometry. Acs Combinatorial Science. 13: 347-50. PMID 21639106 DOI: 10.1021/Co2000373  0.55
2010 Gurard-Levin ZA, Kilian KA, Kim J, Bähr K, Mrksich M. Peptide arrays identify isoform-selective substrates for profiling endogenous lysine deacetylase activity Acs Chemical Biology. 5: 863-873. PMID 20849068 DOI: 10.1021/Cb100088G  0.62
2010 Mwakwari SC, Guerrant W, Patil V, Khan SI, Tekwani BL, Gurard-Levin ZA, Mrksich M, Oyelere AK. Non-peptide macrocyclic histone deacetylase inhibitors derived from tricyclic ketolide skeleton Journal of Medicinal Chemistry. 53: 6100-6111. PMID 20669972 DOI: 10.1021/Jm100507Q  0.612
2009 Gurard-Levin ZA, Kim J, Mrksich M. Combining mass spectrometry and peptide arrays to profile the specificities of histone deacetylases Chembiochem. 10: 2159-2161. PMID 19688789 DOI: 10.1002/Cbic.200900417  0.612
2008 Gurard-Levin ZA, Mrksich M. Combining self-assembled monolayers and mass spectrometry for applications in biochips Annual Review of Analytical Chemistry. 1: 767-800. PMID 20636097 DOI: 10.1146/Annurev.Anchem.1.031207.112903  0.548
2008 Gurard-Levin ZA, Mrksich M. The activity of HDAC8 depends on local and distal sequences of its peptide substrates Biochemistry. 47: 6242-6250. PMID 18470998 DOI: 10.1021/Bi800053V  0.598
Show low-probability matches.